Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
A rich training program featuring four main areas addressed from both Working Groups’ perspective.
A rich training program featuring four main areas addressed from both Working Groups’ perspective:
European Society of Cardiology
The European Heart House
2035 Route des Colles
CS 80179 Biot
06903 Sophia Antipolis Cedex, France
The Educational Training Programme is composed of 8 sessions aiming at:
The ESC will submit this Educational Training Programme to the UEMS-EACCME for accreditation.
30 travel grants up to 400€ each will be awarded by the Working Groups.
Mandatory eligibility criteria: in order to be eligible for a travel grant, you must be:
1st round of applications was open from Monday 25 February to Wednesday 17 April.
A waiting list is now open, so in case you did not get a chance to apply during the first round, please submit your application by Sunday 19 May.
Hospitality costs are covered by the ESC Working Groups.
Registered participants will be accommodated at the Hôtel AC Ambassadeur Antibes - Juan-les-Pins, 50-52 Chemin des Sables, 06160 Antibes, on 12 and 13 June.
Lunches will be provided and transfers will be organised from the European Heart House (course venue) to the Hotel AC Ambassadeur (hotel). Registered participants will receive further information about logistics in due course.
Young (Students / PhD): 150€
Due to limited seats, only the first 70 registered participants will be accepted.
Registration deadline is Sunday 2 June.
Scientific Coordinators and Contributors are members of the Working Groups' Nuclei.
Preliminary faculty members list:
Working Group on Aorta (WGA)
Working Group on Thrombosis (WGT)
Special Guest: Lars Wallentin
All sessions have 4 speakers with 20min per talk and 10min of common final discussion.
13:00-14:30: Registration and lunch
14:30-14:50: Welcome message from the Working Groups Chairpersons - V Aboyans and D Sibbing
14:50-16:20: Session 1
Focus on the pathophysiology of endothelium and haemostasis / thrombosis
Chairs: V Aboyans and D Sibbing
16.45-18.15: Session 2
Antithombotic strategies in peripheral arteries
Chairs: M Brodmann and O Schlager
Antithrombotic therapies: how to assess bleeding risk and its severity?
Lecturer: Lars Wallentin
19.00-20.30: Networking cocktail at the Heart House
09:00-10:30: Session 1
Combined antithrombotic strategies in CAD
Chairs: D Sibbing and T Geisler
11:00-12:30: Session 2
Antithrombotic therapies in special populations
Chairs: D Gorog and M De Carlo
12:30-14:00: Lunch and networking
14:00-15:30: Session 1
Antithrombotic therapies and diabetes and/or metabolic syndrome
Chairs: J Rodriguez-Palomares and B Rocca
The haemostatic imbalance in type 2 diabetes and Metabolic Syndrome - G Vilahur GarciaAntithrombotic strategies in diabetic patients with CAD - M De CarloAntithrombotic strategies in diabetic patients with PAD - C Espinola-KleinObesity and antithrombotic strategies in arterial and venous diseases - R Storey
16:00-17:30: Session 2
Focus on venous thromboembolism
Chairs: A Rubboli and E Messas
18:00-18:40: Debate Session
Antithrombotic strategies in asymptomatic patients: Pros and Cons
Chairs: J Morais and D Terentes-Printzios
18:40: Wrap up
Focus on venous thromboembolism and cancer
20 min +10 common discussion at the end
Chairs: C Espinola-Klein and G Vilahur Garcia
10:45-12:15: Session 2
Antithrombotic therapies and cardiovascular devices
Chairs: T Geisler and D Terentes-Printzios
12:15-12:30: Closing remarks - V Aboyans and G Vilahur Garcia
This educational programme is accredited for CME Credit(s). Each participant should claim only those hours of credits that have actually been spent in the educational activity.
Find out more about CME and accreditation.
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
This course is supported by Bayer AG and Sanofi in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsor.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved